S.3019

The No Big Blockbuster Bailouts Act modifies the Medicare Drug Price Negotiation Program to exclude orphan drugs from price negotiations.

The No Big Blockbuster Bailouts Act amends the Social Security Act to change how orphan drugs are treated under the Medicare Drug Price Negotiation Program. Specifically, it excludes orphan drugs from price negotiations. An orphan drug is defined as a drug for one or more rare diseases or conditions with only approved indications for such rare diseases or conditions. The changes apply to initial price applicability years starting on or after January 1, 2028.